29 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... Endocrinology #Pharmacology
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... #pharmacology #dm2 ... #diabetes #medications
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication Table ... Antiarrhythmic #Medications ... #Table #Classification ... #Classes #Cardiology ... #Pharmacology
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
resuscitation #table ... #criticalcare # ... pharmacology #dosing ... #medications #Comparison
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Comorbidities: • Stable ... Dissection • CKD, DM ... Comorbidities #pharmacology ... #table #management
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
kidney), which causes ... glucose in the urine ... excretion in the urine ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid - Indications ... and Pharmacology ... of Excretion: Urine ... Tranexamic #Acid #Indications ... #Pharmacology #
Common Vasopressors and Inotropes
Norepinephrine (NE)
 - Indication: Distributive shock (1st line for septic shock), Cardiogenic shock
Vasopressin - Indication ... Bradyarrhythmias, Some cases ... Inotropes #comparison #table ... #pharmacology # ... criticalcare
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Januvia) - Once/day tablet ... not definitively cause ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... Diabetes #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology # ... comparison #table